Mark X. Sliwkowski

机构：Molecular Oncology (United States)

发表论文 302 篇 · 总被引 32585 次 · h-index 61

代表论文

• The HER2-directed antibody-drug conjugate DHES0815A in advanced and/or metastatic breast cancer: preclinical characterization and phase 1 trial results (2024 · Nature Communications · 被引 50)
• Supplementary Table 1-2 from Effects of Anti-VEGF on Pharmacokinetics, Biodistribution, and Tumor Penetration of Trastuzumab in a Preclinical Breast Cancer Model (2023)
• Supplementary Figure 1 from Effects of Anti-VEGF on Pharmacokinetics, Biodistribution, and Tumor Penetration of Trastuzumab in a Preclinical Breast Cancer Model (2023)
• Data from Antitumor Effects of MEHD7945A, a Dual-Specific Antibody against EGFR and HER3, in Combination with Radiation in Lung and Head and Neck Cancers (2023)
• Data from Mechanisms of Acquired Resistance to Trastuzumab Emtansine in Breast Cancer Cells (2023)
• Supplementary Materials and Methods and Supplementary Figure Legends from HER2-Targeted Polyinosine/Polycytosine Therapy Inhibits Tumor Growth and Modulates the Tumor Immune Microenvironment (2023)